,,iv #aag? ,,congress #a/ ,session ,h4 ,,res4 #hji ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,novemb] #ah1 #bjba,mr4 ,danny ,k4 ,davis ( ,ill9ois submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,support+ ! designation ( ! ?ird week ( ,novemb]1 ,novemb] #ad to ,novemb] #bj1 #bjba1 z ,,t$ ,aw>5ess ,week4 ,:]eas ! ,national ,in/itutes ( ,heal? def9es a r>e disease z a condition t affects few] ?an #bjj1jjj p 9 ! ,unit$ ,/ates2 ,:]eas curr5tly !re are approximately #g1jjj r>e diseases impact+ almo/ #cj1jjj1jjj ,am]icans2 ,:]eas ?yroid eye disease 7,,t$7 is a s]i\s1 progressive1 & r>e autoimmune condition 9 :i* ! body's immune sy/em mi/ak5ly attacks heal?y muscle & fat tissue beh9d ! eye1 caus+ inflammation & sc> tissue to =m2 ,:]eas p liv+ ) ,,t$ (t5 h debilitat+ symptoms ( eye bulg+1 d\ble vision1 blurr$ vision1 pa91 & facial disfigurem5t1 & 9 sev]e cases1 ,,t$ c lead to bl9dness2 ,:]eas p liv+ ) ,,t$ are (t5 impact$ by long-t]m functional1 psy*osocial1 & economic burd5s1 includ+ ! inability to "w or p]=m activities ( daily liv+2 ,:]eas ! exact und]ly+ process by :i* ,,t$ occurs is n fully und]/ood1 & ,,t$ is a s]i\s1 vision-?reat5+ condition t c get worse ov] "t2 ,:]eas ,,t$ is a r>e disease & is e/imat$ to h a preval5ce ( #af p] #ajj1jjj wom5 9 ! ,unit$ ,/ates1 & #b4i p] #ajj1jjj m5 9 ! ,unit$ ,/ates2 ,:]eas a diagnosis ( ,,t$ is bas$ ^u id5tification ( *>act]i/ic symptoms1 a detail$ pati5t hi/ory1 a ?or\gh cl9ical evaluation1 & a v>iety ( specializ$ te/s2 & ,:]eas !re is a g5etic compon5t to ! condition1 & p :o h a family memb] ) ! disease or a family memb] ) an autoimmune disease are at a great] risk ( develop+ ! condition3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives recognizes ^? lead+ advocacy organizations1 includ+ ! ,autoimmune ,association & ,prev5t ,bl9dness1 t are engag$ 9 disease aw>5ess & pati5t support ab\t ,,t$1 & supports ! designation ( a ,,t$ ,aw>5ess ,week4